14
Recently, the Affiliated Cancer Hospital of ZZU has made new progress in Chimeric Antigen Receptor （CAR） T cells in the treatment of relapsed and refractory hematological neoplasms. The related rese...
12
Recently, ZZU team of Prof. Dong Zigang published the latest research results “ARC is a Critical Protector against Inflammatory Bowel Disease (IBD) and IBD-associated Colorectal Tumorigenesis” in th...
10
Recently, the team of Prof. Zhang Yi from the First Affiliated Hospital of ZZU has made new progress in the research of colorectal cancer tumor immune microenvironment and new targets for immunotherap...
04
Recently, the 2019 National Key Research and Development Program “Active Health and Aging Technology Response”, which was led by the Fifth Affiliated Hospital of ZZU, was approved and announced by t...
Internal
E-mail
Jobs
中文
